Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bendix Carstensen

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Diabetologia|March 1, 2016
Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individualsBendix Carstensen, Stephanie H Read, Søren Friis, et al.
International Journal of Epidemiology|January 24, 2012
The influence of hip circumference on the relationship between abdominal obesity and mortalityAdrian J Cameron, Dianna J Magliano, Jonathan E Shaw, et al.
Cardiovascular Diabetology|September 27, 2020
Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trialChristian Stevns Hansen, Louise Lundby-Christiansen, Lise Tarnow, et al.
Journal of Diabetes Research|October 21, 2024
Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) StudyGisle Langslet, Thomas Nyström, Dorte Vistisen, et al.
Diabetologia|March 22, 2022
Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohortsPaz L D Ruiz, Lei Chen, Jedidiah I Morton, et al.
The Lancet. Diabetes & Endocrinology|November 14, 2024
Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortiumDianna J Magliano, Lei Chen, Jedidiah I Morton, et al.
Diabetologia|April 21, 2026
Age- and sex-specific trends in dementia mortality among people with and without diabetes: a multi-country population-based analysisKanika Mehta, Jedidiah I Morton, Lei Chen, et al.
BMJ Open|February 27, 2016
Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus-the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trialLouise Lundby-Christensen, Lise Tarnow, Trine W Boesgaard, et al.
BMJ Open|February 27, 2016
Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trialLouise Lundby-Christensen, Allan Vaag, Lise Tarnow, et al.
Kidney International|November 13, 2018
Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetesGuozhi Jiang, Andrea On Yan Luk, Claudia Ha Ting Tam, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Diabetologia|March 1, 2016
Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individualsBendix Carstensen, Stephanie H Read, Søren Friis, et al.
International Journal of Epidemiology|January 24, 2012
The influence of hip circumference on the relationship between abdominal obesity and mortalityAdrian J Cameron, Dianna J Magliano, Jonathan E Shaw, et al.
Cardiovascular Diabetology|September 27, 2020
Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trialChristian Stevns Hansen, Louise Lundby-Christiansen, Lise Tarnow, et al.
Journal of Diabetes Research|October 21, 2024
Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) StudyGisle Langslet, Thomas Nyström, Dorte Vistisen, et al.
Diabetologia|March 22, 2022
Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohortsPaz L D Ruiz, Lei Chen, Jedidiah I Morton, et al.
The Lancet. Diabetes & Endocrinology|November 14, 2024
Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortiumDianna J Magliano, Lei Chen, Jedidiah I Morton, et al.
Diabetologia|April 21, 2026
Age- and sex-specific trends in dementia mortality among people with and without diabetes: a multi-country population-based analysisKanika Mehta, Jedidiah I Morton, Lei Chen, et al.
BMJ Open|February 27, 2016
Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus-the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trialLouise Lundby-Christensen, Lise Tarnow, Trine W Boesgaard, et al.
BMJ Open|February 27, 2016
Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trialLouise Lundby-Christensen, Allan Vaag, Lise Tarnow, et al.
Kidney International|November 13, 2018
Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetesGuozhi Jiang, Andrea On Yan Luk, Claudia Ha Ting Tam, et al.
Pageof 12